Screener
Rhythm Pharmaceuticals, Inc. RYTM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Accrued dividends on convertible preferred stock | (1,104) | (1,322) |
| Net loss attributable to common stockholders | $(56,743) | $(50,820) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.83) | $(0.81) |
| Weighted-average common shares outstanding, basic and diluted | 67,974,193 | 63,059,165 |
| Net loss | $(55,639) | $(50,820) |
| Other comprehensive income (loss): | ||
| Foreign currency translation adjustment | 1,784 | (2) |
| Unrealized gain (loss), net on marketable securities | $(544) | (10) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s shares (diluted)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported shares (diluted) of 68M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s shares (diluted) increased by 7.8% year-over-year, from 63.1M to 68M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s shares (diluted) has grown at a 6.8% compound annual growth rate (CAGR), from 198.6M to 258M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude